Thymoglobulin versus ATGAM induction therapy in pediatric kidney transplant recipients: A single-center report

Transplantation

Volumn 79, Issue 8, 2005, Pages 958-963

  Khositseth, Sookkasem ^a   Matas, Arthur ^a   Cook, Marie E ^a   Gillingham, Kristen J ^a   Chavers, Blanche M ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b MMC 195 ^*  (United States)

Author keywords

Infection; Pediatric kidney transplantation; Rejection; Thymoglobulin

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; POLYCLONAL ANTIBODY; PREDNISONE; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADOLESCENT; ARTICLE; CHRONIC GRAFT REJECTION; COHORT ANALYSIS; COMPARATIVE STUDY; DIARRHEA; EPSTEIN BARR VIRUS; FEMALE; FOLLOW UP; GRAFT INFECTION; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LYMPHOMA; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MONITORING; PEDIATRIC SURGERY; PRIORITY JOURNAL; RECIPIENT; SCHOOL CHILD; VIRUS INFECTION;

ADOLESCENT; ANTILYMPHOCYTE SERUM; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOTHERAPY; INFANT; INFECTION; KIDNEY TRANSPLANTATION; MALE; SURVIVAL RATE; T-LYMPHOCYTES; TREATMENT OUTCOME;

EID: 17844405620     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000158325.12837.A2     Document Type: Article

References (19)

1. Szczech LA, Berlin JA, Aradhye S, et al. Effect of anti-lymphocyte induction therapy on renal allograft survival: a meta-analysis. J Am Soc Nephrol 1997; 8: 1771-1777.
2. Szczech LA, Berlin JA, Feldman HI. The effect of antilymphocyte induction therapy on renal allograft survival. A meta-analysis of individual patient-level data. Anti-Lymphocyte Antibody Induction Therapy Study Group. Ann Intern Med 1998; 128: 817-826.
3. Tejani AH, Stablein DM, Sullivan EK, et al. The impact of donor source, recipient age, pre-operative immunotherapy and induction therapy on early and late acute rejections in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Transplant 1998; 2: 318-324.
4. Benfield MR, McDonald R, Sullivan EK, et al. The 1997 Annual Renal Transplantation in Children Report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Transplant 1999; 3: 152-167.
5. McDonald R, Donaldson L, Emmett L, et al. A decade of living donor transplantation in North American children: the 1998 Annual Report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Transplant 2000; 4: 221-234.
6. Elshihabi I, Chavers B, Donaldson L, et al. Continuing improvement in cadaver donor graft survival in North American children: the 1998 Annual Report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Transplant 2000; 4: 235-246.
7. Ault BH, Honaker MR, Osama Gaber A, et al. Short-term outcomes of Thymoglobulin induction in pediatric renal transplant recipients. Pediatr Nephrol 2002; 17: 815-818.
8. Birk PE, Matas AJ, Gillingham KJ, et al. Risk factors for chronic rejection in pediatric renal transplant recipients-a single-center experience. Pediatr Nephrol 1997; 11: 395-398.
9. Chavers BM, Gillingham KJ, Matas AJ. Complications by age in primary pediatric renal transplant recipients. Pediatr Nephrol 1997; 11: 399-403.
10. Bunchman TE, Fryd DS, Sibley RK, et al. Manifestations of renal allograft rejection in small children receiving adult kidneys. Pediatr Nephrol 1990; 4: 255-258.
11. Harris NL, Ferry JA, Swerdlow SH. Posttransplant lymphoproliferative disorders: summary of Society for Hematopathology Workshop. Semin Diagn Pathol 1997; 14: 8-14.
12. Goggins WC, Pascual MA, Powelson JA, et al. A prospective, randomized, clinical trial of intraoperative versus postoperative Thymoglobulin in adult cadaveric renal transplant recipients. Transplantation 2003; 76: 798-802.
13. Brennan DC, Flavin K, Lowell JA, et al. A randomized double-blinded comparison on Thymoglobulin versus ATGAM for induction immunosuppressive therapy in adult renal transplant recipients. Transplantation 1999; 67: 1011-1018.
14. Benfield MR, McDonald RA, Bartosh S, et al. Changing trends in pediatric transplantation: 2001 Annual Report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Transplant 2003; 7: 321-335.
15. Hardinger KL, Schnitzler MA, Miller B, et al. Five-year follow up of Thymoglobulin versus ATGAM induction in adult renal transplantation. Transplantation 2004; 78: 136-141.
16. Parisi F, Danesi H, Squitieri C, et al. Thymoglobulin use in pediatric heart transplantation. J Heart Lung Transplant 2003; 22: 591-593.
17. Filippo S, Boissonnat P, Sassolas F, et al. Rabbit antithymocyte globulin as induction immunotherapy in pediatric heart transplantation. Transplantation 2003; 75: 354-358.
18. Srivastava T, Zwick DL, Rothberg PG, et al. Posttransplant lymphoproliferative disorder in pediatric renal transplantation. Pediatr Nephrol 1999; 13: 748-754.
19. Nocera A, Ghio L, Dall'Amico R, et al. De novo cancers in paediatric renal transplant recipients: a multicentre analysis within the North Italy Transplant Programme (NITP), Italy. Eur J Cancer 2000; 36: 80-86.